DETROIT, Feb. 28, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp . (OTCQB:CTLE), a nanotechnology research and development company focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including consumer products, energy and healthcare, is pleased to announce today that Mr. Francis F. Mandy has joined Nano Labs Strategic Advisory Board.
Mr. Mandy is an internationally recognized expert in the field of HIV and Immunology where he has held a variety of senior positions over the course of a 40 year career, mostly with the Public Health Agency of Canada and its predecessor agencies.
Prior to his retirement from the Canadian Government, Mr. Mandy's most recent position was Chief of the National HIV Immunology Laboratory with the Public Health Agency of Canada. Mr. Mandy has authored 50 publications, most of which are relevant to clinical diagnostics, quality control and quality laboratory management procedures related to HIV and other infectious diseases both in resource poor and rich countries.Following retirement after a successful career in the public health sector, Mr. Mandy has worked in consulting roles with other public sector agencies around the globe, including CDC, universities and private enterprises, he is an associate editor of an international journal, co-founded a company conducting research in the field of immunology and taken on senior management positions with biotechnology companies. "I am very proud to join the Company and am excited at the prospect of introducing next-generation thinking and products to my colleagues and networks globally. The core belief of Nano Labs to enhance access to better health and nutrition, and to improve quality of life into everyday products, and create revolutionary new products for me is the most exciting reason to be joining the company," stated Mr. Mandy. "I believe that nanotechnology is changing the face of business - especially in the fields of bioscience and healthcare and I am very much looking forward to being a part of that change."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV